Regulations and compliance · Practical guide

21 CFR 211.194: complete laboratory records

A signed result alone is an incomplete laboratory record. For covered drug CGMP activities, §211.194 sets out the information and data that laboratory records must contain. The sample may be in the LIMS, measurements in the instrument system, calculations in a spreadsheet and the review on paper. Connect these records and document why the provision applies to the activity in question.

Table of contents

At a glance

What data and information make up a complete laboratory record under 21 CFR 211.194?

Section 211.194 requires complete data from the laboratory tests covered, including the sample, method, weight or measure where applicable, calculations, results and person performing the work. Paragraph (a)(8) also requires a documented second-person review. Electronic component records may also fall under Part 11. Preserve the complete traceable context of the test. A summary report does not replace the underlying complete test data.

  • Results, method, original data, and calculations must be clearly interpretable together.
  • §211.194(a)(8) explicitly includes a second review of the affected laboratory records.
  • Methodology changes, reagents, and calibrations have their own validation requirements.

Clarify the laboratory scope prior to the record list.

Part 211 addresses, pursuant to §211.1, the requirements concerning the manufacture, processing, packaging, or storage of finished pharmaceuticals, including the specified exemptions and special provisions. Therefore, §211.194 is not a universal regulation applicable to every research, environmental, or clinical laboratory investigation. This article specifically references an assumed example from the relevant Drug-CGMP domain.

Paragraph (a) requires complete data from all tests recorded therein that are necessary to establish compliance with specified specifications and standards. Define which test is performed and for what purpose the result is used. Only from this can a reliable test record inventory be established. The software product used does not determine the scope of applicability.

Sources: [1] [2]

What pertains beyond the result value

§211.194(a)(1) through (6) specifies, among other things, sample description, origin and quantity reference, relevant batch or lot numbers, time stamps, methods employed, required weight or volume specifications, complete test data, calculations, and comparison of results to established specifications. Spectra and diagrams must be appropriately identified. The specific details depend on the test performed.

The following matrix serves as an internal reference tool for an approved electronically supported laboratory test. It does not prescribe universal file formats. The benefit lies in clearly defining the actual storage location for each part record and its specific reference to the test.

Example: Test T-42 batch record inventory
record batch componentFilled example referenceLink to be testedPrimary reference
Probe P-42, Batch C-17, Receipt and withdrawal documented The probe and origin match the tested material. §211.194(a)(1)
Method M-07, current version 3 The applied method and actual conditions are traceable. §211.194(a)(2)
Data Data set D-42 with test identity Required data including associated context remains linked. §211.194(a)(4)
Calculation B-42 with units and dilution factor Calculation uses the correct input data. §211.194(a)(5)
Result E-42 compared to the specified standard The comparison utilizes the requirements applicable to this test. §211.194(a)(6)
Execution and Verification Executing employee; second reviewer Activity, date, and review refer to the complete record. §211.194(a)(7)–(8)

Sources: [2] [3]

Properly manage method reference and method changes

Clause (a)(2) requires a statement regarding the method used and the location of the data that substantiates its accuracy and reliability for the intended use. For certain recognized, unchanged methods, an appropriate reference may suffice. However, suitability under actual usage conditions must still be verified. A known method number alone does not fulfill this requirement.

Clause (b) requires complete records of any changes to an established test method, including the rationale for the change. The data must demonstrate that the modified method produces at least equivalent accuracy and reliability for the tested material as the established method. Therefore, clearly document whether the method itself, its technical implementation, or a data interpretation decision has been altered. When reprocessing, it must be clearly evident which version was applied to which data. Do not overwrite the prior classification with a single, apparent current status.

Sources: [2] [3]

A calculated relationship rather than isolated figures

Calculation example: 0.250 g of a hypothetical substance is dissolved in 100 mL. Then, 2 mL are pipetted and diluted to 20 mL. This example is a theoretical calculation assuming a complete solution without additional correction factors. This example does not represent an approved analytical method and contains no actual product specification.

The initial solution contains 250 mg ÷ 100 mL = 2.5 mg/mL. The dilution factor is 20 ÷ 2 = 10; the diluted solution therefore contains 0.25 mg/mL. In the error scenario, 5 mL is inadvertently used instead of 2 mL as the volume withdrawn. This results in a concentration of 0.625 mg/mL. The numerical value is mathematically sound but arises from an incorrect input.

Sample calculation: Calculation and verification matrix
StepCorrect basis for the expected resultFailure scenarioExpected inspection
Convert the sample weight 0.250 g × 1,000 = 250 mg 0.250 is accepted without verification as mg. Check unity and transfer against the source record.
Starting concentration 250 mg ÷ 100 mL = 2.5 mg/mL An incorrect weight affects all downstream values Check the inputs and calculation together.
Dilution factor 20 mL ÷ 2 mL = 10 20 mL ÷ 5 mL = 4 Compare the actually used aliquot with the record.
Final concentration 2.5 mg/mL ÷ 10 = 0.25 mg/mL 2.5 mg/mL ÷ 4 = 0.625 mg/mL Investigate errors prior to use of results.
Second inspection Source data, factors, and comparison included Only the final numerical value is read. Scope must include accuracy, completeness, and conformity to standards.

Sources: [2] [4]

The second party verifies the test linkage

§211.194(a)(7) requires the initials or signature of the performing individual and the execution date. Paragraph (a)(8) requires the initials or signature of a second person as evidence of review of the original records for accuracy, completeness, and conformity to established standards. This constitutes a specific laboratory responsibility within the specified scope, not a general two-person rule applicable to every activity in every GxP system.

In the electronic process, specify which data the second examiner can actually see and assess. A completed task in the workflow does not prove the required scope alone. If electronic signatures are used in the Part-11 scope, their requirements must be considered in addition. §211.194 itself does not prescribe a specific software button and no specific electronic signature product.

Sources: [2] [5] [3]

Include reagents, calibration, and electronic records

Paragraphs (c) to (e) require additional complete records, among other things, relating to the evaluation and standardization of reference standards, reagents, and standard solutions, periodic instrument calibration, and stability testing. These informations are not equivalent to individual result values. Determine which of these require the execution and assessment of your test.

The FDA Guidance of 2018 emphasizes the importance of context and the distinction between static and dynamic records for electronic data. A data output may constitute an appropriate component for certain data types, but its retention does not automatically ensure the complete content or the significance of dynamic analysis data. Retention and availability are determined by applicable requirements, not by a one-size-fits-all deadline for all laboratory information.

Sources: [2] [3] [6]

Checklist for a Complete Laboratory Test Record

The following internal checklist supports a concrete assessment of current status. Document any missing components and the associated intended use. A completed checklist does not constitute evidence that the information contained therein is factually accurate; it establishes the foundational framework for subsequent evaluation.

  • The scope of 211.194 and the purpose of the test are clarified.
  • Probe, origin, batch number, and relevant time stamps are clearly defined.
  • The actually used method version and suitability documentation are retrievable.
  • Required original data and contextual information are assigned.
  • Calculations include understandable units and factors.
  • Results are compared against the appropriate predefined requirements.
  • Performing employee, date, and second inspection are documented.
  • Methodology changes and additional required laboratory records have been considered.
  • Electronic transfers and storage maintain the required traceability linkage.

Sources: [2] [3]

Start with a complete test

For the first inventory review, select a representative test involving real system transitions. Trace the sample from receipt through to result utilization across all processing stages. Laboratory personnel shall explain the technical significance; IT shall assess file linking, access permissions, and retrieval capabilities. The responsible quality unit shall evaluate the evidence process within the defined accountability framework.

Effort arises particularly in distributed calculations, multiple method stations, ambiguous original data, and a review view that obscures relevant information. Assign supplier documentation only to functions it actually supports. A platform description neither replaces proper independent calculations nor a complete laboratory record.

Sources: [2] [3]

Project experience and collaboration

Trace the sample through to the complete laboratory record

With the laboratory, QA and IT, we trace a selected test from sample receipt to the approved result. We follow measurement data, method version, calculations and the documented second review in the responsible systems. A clearer mapping rule may resolve a missing link between raw data and report. Separate applications also need interface tests. Your team assesses existing gaps through its deviation procedure. We support investigation and future controls without representing missing historical records as present.

Frequently asked questions about Laboratory records

Does 211.194 apply to every laboratory with FDA customers?

No. The specific product and activity scope, along with the applicable documentation requirements, are decisive. §211.194 falls under Part 211 and is not a universal regulation applicable to every research or clinical investigation. A customer interaction initiated under FDA oversight alone does not determine which laboratory records fall under this regulation.

Sources: [1] [2]

Does a signed analysis certificate suffice?

No. An analysis certificate summarizes results. Section 211.194(a) requires complete data from the recorded tests, including measurement data, charts, and spectra (a)(4), calculations (a)(5), and documented secondary review of the original records (a)(8). A summary certificate does not replace these laboratory records.

Sources: [2]

Must all laboratory records be stored in a single file?

Such a file specification does not include §211.194. However, distributed records must be complete, clearly attributable, and available in the required extent. Crucially, a test evaluation must be traceable, and its components must not become fragmented due to ambiguous references or lost linkages.

Sources: [2] [6]

Is the second inspection actually required?

Yes, §211.194(a)(8) specifically requires for the affected laboratory records the initials or signature of a second person as evidence of verification for accuracy, completeness, and conformity to established standards. This specific requirement may neither be overlooked nor generically applied to all other GxP activities.

Sources: [2]

Must the second reviewer always electronically sign off?

§211.194(a)(8) mentions initials or signatures, but does not prescribe a specific electronic procedure. If an electronic signature is used in the scope of Part 11, its requirements are added. Selection of the procedure must fit the entire record and review process.

Sources: [2] [5]

Is a literature reference sufficient for an accepted method?

Clause (a)(2) allows reference to an established, unchanged method under the specified conditions. However, the suitability under actual usage conditions must still be verified. Therefore, confirm that the method, material, and execution are indeed captured from this reference.

Sources: [2]

What must be documented during a method change?

§ 211.194(b) requires complete records of changes to established test methods, including the rationale and comparative data: The modified method for the tested material must yield at least equivalent precision and reliability compared to the established method. Maintain clear and traceable documentation of the affected method versions and the comparative data basis. A new method name alone does not justify the change.

Sources: [2]

Can prior evaluation results be replaced by the final result?

The final result must not obscure any required prior data or the rationale for a subsequent reprocessing. The FDA Guidance clarifies the retention of reprocessing results and the traceable handling of invalid data. The records affected must be determined based on the specific test and applicable obligations.

Sources: [3] [2]

Is a mathematically correct tabular value already a valid laboratory record?

No. The calculation may be correct, yet still employ an incorrect single weighing, unit, or dilution factor. Verify all inputs, factors, method, and result comparison together. In the calculation example presented in this article, the error case of 0.625 mg/mL precisely illustrates the difference between correct mathematical execution and the appropriate scientific context.

Sources: [2] [4]

Must all laboratory information be retained indefinitely?

No. Storage conditions shall be determined in accordance with applicable requirements and the required record volume. §211.180 contains specific provisions; therefore, no unlimited general exemption period is implied. Required data must not be lost solely because a concise closing report remains available.

Sources: [6] [2] [3]

Sources and review date

Source date: 7 October 2026. eCFR notice period until 5 October 2026; separate consideration of binding regulatory text and non-binding FDA Guidance. Examples and tables are internal work aids and do not represent completed product testing.

  1. 21 CFR §211.1 – ScopeeCFR notice until 05.10.2026; Scope: Drug-CGMP.
  2. 21 CFR §211.194 – Laboratory recordseCFR notice until 05.10.2026; paragraphs (a)(1)–(8), (b)–(e).
  3. FDA: Data Integrity and Compliance With Drug CGMP – Questions and AnswersFinal Guidance December 2018; in particular Questions 1–3, 9–12, 14 and 17.
  4. 21 CFR §211.68 – Automatic, mechanical, and electronic equipmenteCFR notice until 05.10.2026; paragraphs (a)–(c).
  5. 21 CFR Part 11 – Electronic Records; Electronic SignatureseCFR display until 05.10.2026; §§11.1–11.300.
  6. 21 CFR §211.180 – General requirementseCFR Notice until 05.10.2026: Paragraphs (a) and (b) relate to retention periods, paragraphs (c) and (d) relate to availability and copies.

Sources checked: .

Daniel Herrmann, Daniel Herrmann Consulting

Daniel Herrmann Consulting

Jointly develop the specific evidence process

We support you in inventorying distributed laboratory records, verifying electronic transfers, and selectively addressing gaps in the required scientific traceability evidence.

  • Computer system validation →

    Bring your GxP systems into validated operation, from laboratory software, MES and eQMS to ERP. We define the scope, plan risk-based tests using GAMP 5 and hand the evidence to QA for release.

Send a project enquiry Customer testimonials →